Table 6 |
||||||
|
VAS that assessed physician's and patients' overall opinions on improvementa during treatment (intent-to-treat data set). |
||||||
|
Variable |
Treatment group |
n |
Week 1 |
Week 2 |
Week 3 |
Week 4 |
|
|
||||||
|
Physician's overall opinion |
DJW |
98b |
56.69 (11.32) |
57.30 (11.32) |
60.06 (12.47) |
62.55 (11.67) |
|
Diclofenac |
97b |
59.84 (7.53) |
59.63 (7.74) |
62.11 (7.57) |
63.35 (7.90) |
|
|
Patients' overall opinion |
DJW |
98b |
32.58 (23.18) |
45.53 (24.74) |
58.10 (26.84) |
71.13 (24.68) |
|
Diclofenac |
97b |
37.48* (18.59) |
50.24 (18.79) |
62.88 (19.75) |
75.30 (17.95) |
|
|
|
||||||
|
Data represent mean (SD). a0 = no improvement, 100 = best possible improvement. b2 patients in the DJW group and 3 patients in the diclofenac group could not be assessed due to loss to follow up or withdrawal during week 0. *p < 0.05 versus the DJW group at the corresponding week. |
||||||
|
Teekachunhatean et al. BMC Complementary and Alternative Medicine 2004 4:19 doi:10.1186/1472-6882-4-19 |
||||||
